Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Lung infection | 1 |
| INFLIXIMAB, RECOMBINANT | Malignant melanoma | 1 |
| INFLIXIMAB, RECOMBINANT | Mass | 1 |
| INFLIXIMAB, RECOMBINANT | Meningitis tuberculous | 1 |
| INFLIXIMAB, RECOMBINANT | Metabolic syndrome | 1 |
| INFLIXIMAB, RECOMBINANT | Multiple organ dysfunction syndrome | 1 |
| INFLIXIMAB, RECOMBINANT | Mycobacterium avium complex infection | 1 |
| INFLIXIMAB, RECOMBINANT | Nasopharyngitis | 1 |
| INFLIXIMAB, RECOMBINANT | Neutropenia | 1 |
| INFLIXIMAB, RECOMBINANT | Non-alcoholic steatohepatitis | 1 |
| INFLIXIMAB, RECOMBINANT | Oedema peripheral | 1 |
| INFLIXIMAB, RECOMBINANT | Opportunistic infection | 1 |
| INFLIXIMAB, RECOMBINANT | Orbital apex syndrome | 1 |
| INFLIXIMAB, RECOMBINANT | Orchitis | 1 |
| INFLIXIMAB, RECOMBINANT | Osteoporosis | 1 |
| INFLIXIMAB, RECOMBINANT | Pallor | 1 |
| INFLIXIMAB, RECOMBINANT | Pancytopenia | 1 |
| INFLIXIMAB, RECOMBINANT | Pathogen resistance | 1 |
| INFLIXIMAB, RECOMBINANT | Perirectal abscess | 1 |
| INFLIXIMAB, RECOMBINANT | Pleural effusion | 1 |
Total Records: 276 Number of Pages: 14